These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28776637)

  • 1. In-clinic application of ingenol mebutate 0.015% gel for actinic keratosis in large areas of the face is feasible and attracts a high rate of patient satisfaction: Results of a questionnaire.
    Strydom F
    Australas J Dermatol; 2018 Aug; 59(3):237-239. PubMed ID: 28776637
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes.
    Augustin M; Tu JH; Knudsen KM; Erntoft S; Larsson T; Hanke CW
    J Am Acad Dermatol; 2015 May; 72(5):816-21. PubMed ID: 25770879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response.
    Pampena R; Benati E; Borsari S; Bombonato C; Lombardi M; Raucci M; Mirra M; Lallas A; Apalla Z; Papadimitriou I; Moscarella E; Kyrgidis A; Argenziano G; Pellacani G; Longo C
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1461-1468. PubMed ID: 29356164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring Ingenol Mebutate Gel Treatment of Actinic Keratoses by Reflectance Confocal Microscopy.
    López Estebaranz JL; Pampín Franco A; Gamo Villegas R; Floristán U
    Acta Derm Venereol; 2017 May; 97(5):646-648. PubMed ID: 28093603
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.
    Stockfleth E; Harwood CA; Serra-Guillén C; Larsson T; Østerdal ML; Skov T
    Br J Dermatol; 2018 Feb; 178(2):433-442. PubMed ID: 29030864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives.
    Gameiro L; Tovo LFR; Sanches Júnior JA; Aprahamian I
    An Bras Dermatol; 2019 Jul; 94(3):313-319. PubMed ID: 31365660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granuloma faciale successfully treated with ingenol mebutate.
    Bobyr I; Campanati A; Consales V; Giangiacomi M; Diotallevi F; Offidani A
    Dermatol Ther; 2016 Sep; 29(5):325-329. PubMed ID: 27364361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).
    Kim YC; Yang JY; Yoon JS; Jo SJ; Ahn HH; Song KH; Lee DY; Chung KY; Won YH; Kim IH
    Br J Dermatol; 2018 Oct; 179(4):836-843. PubMed ID: 29355904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm
    Hanke CW; Albrecht L; Skov T; Larsson T; Østerdal ML; Spelman L
    J Am Acad Dermatol; 2020 Mar; 82(3):642-650. PubMed ID: 31374304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses.
    Batalla A; Flórez Á; Feal C; Peón G; Abalde MT; Salgado-Boquete L; de la Torre C
    Actas Dermosifiliogr; 2015 Dec; 106(10):e55-61. PubMed ID: 26055975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
    Jim On SC; Hashim PW; Nia JK; Lebwohl MG
    J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled Trials.
    Jim On S; Knudsen KM; Skov T; Lebwohl M
    J Drugs Dermatol; 2017 Feb; 16(2):112-114. PubMed ID: 28300852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
    Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
    Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local skin reactions following the administration of topical ingenol mebutate for actinic keratosis.
    Conde-Taboada A; Mercado B; Aranegui B; González-Guerra E; López-Bran E
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
    Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
    Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
    Moggio E; Arisi M; Zane C; Calzavara-Pinton I; Calzavara-Pinton P
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():161-165. PubMed ID: 27530375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.